|Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway|
J Son, CA Lyssiotis, H Ying, X Wang, S Hua, M Ligorio, RM Perera, ...
Nature 496 (7443), 101-105, 2013
|BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma|
DT Frederick, A Piris, AP Cogdill, ZA Cooper, C Lezcano, CR Ferrone, ...
Clinical cancer research 19 (5), 1225-1231, 2013
|Clinicopathologic correlates of solitary fibrous tumors|
JS Gold, CR Antonescu, C Hajdu, CR Ferrone, M Hussain, JJ Lewis, ...
Cancer 94 (4), 1057-1068, 2002
|Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function|
A Boni, AP Cogdill, P Dang, D Udayakumar, CNJ Njauw, CM Sloss, ...
Cancer research 70 (13), 5213-5219, 2010
|Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology|
MA Tempero, MP Malafa, M Al-Hawary, H Asbun, A Bain, SW Behrman, ...
Journal of the National Comprehensive Cancer Network 15 (8), 1028-1061, 2017
|Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer|
CR Ferrone, G Marchegiani, TS Hong, DP Ryan, V Deshpande, ...
Annals of surgery 261 (1), 12, 2015
|Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors|
T Stylianopoulos, JD Martin, VP Chauhan, SR Jain, B Diop-Frimpong, ...
Proceedings of the National Academy of Sciences 109 (38), 15101-15108, 2012
|Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment|
MC De Jong, H Nathan, GC Sotiropoulos, A Paul, S Alexandrescu, ...
Journal of Clinical Oncology 29 (23), 3140-5, 2011
|Transcriptional control of autophagy–lysosome function drives pancreatic cancer metabolism|
RM Perera, S Stoykova, BN Nicolay, KN Ross, J Fitamant, M Boukhali, ...
Nature 524 (7565), 361-365, 2015
|Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine|
LT Geller, M Barzily-Rokni, T Danino, OH Jonas, N Shental, D Nejman, ...
Science 357 (6356), 1156-1160, 2017
|Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma|
CR Ferrone, DM Finkelstein, SP Thayer, A Muzikansky, ...
Journal of clinical oncology: official journal of the American Society of …, 2006
|High-fat diet enhances stemness and tumorigenicity of intestinal progenitors|
S Beyaz, MD Mana, J Roper, D Kedrin, A Saadatpour, SJ Hong, ...
Nature 531 (7592), 53-58, 2016
|Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a “true” R0 resection?|
IT Konstantinidis, AL Warshaw, JN Allen, LS Blaszkowsky, ...
Annals of surgery 257 (4), 731-736, 2013
|Lymphocytic reaction to colorectal cancer is associated with longer survival, independent of lymph node count, microsatellite instability, and CpG island methylator phenotype|
S Ogino, K Nosho, N Irahara, JA Meyerhardt, Y Baba, K Shima, ...
Clinical Cancer Research 15 (20), 6412-6420, 2009
|Single-cell RNA sequencing identifies extracellular matrix gene expression by pancreatic circulating tumor cells|
DT Ting, BS Wittner, M Ligorio, NV Jordan, AM Shah, DT Miyamoto, ...
Cell reports 8 (6), 1905-1918, 2014
|851 resected cystic tumors of the pancreas: a 33-year experience at the Massachusetts General Hospital|
NP Valsangkar, V Morales-Oyarvide, SP Thayer, CR Ferrone, JA Wargo, ...
Surgery 152 (3), S4-S12, 2012
|Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer|
SK Saha, CA Parachoniak, KS Ghanta, J Fitamant, KN Ross, MS Najem, ...
Nature 513 (7516), 110-114, 2014
|Multi-institutional validation study of the American Joint Commission on Cancer changes for T and N staging in patients with pancreatic adenocarcinoma|
PJ Allen, D Kuk, C Fernandez-del Castillo, O Basturk, CL Wolfgang, ...
Annals of surgery 265 (1), 185, 2017
|Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic …|
TS Hong, JY Wo, BY Yeap, E Ben-Josef, EI McDonnell, LS Blaszkowsky, ...
Journal of Clinical Oncology 34 (5), 460, 2016
|Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a …|
K Sahora, M Mino-Kenudson, W Brugge, SP Thayer, CR Ferrone, ...
Annals of surgery 258 (3), 466-475, 2013